A detailed history of Cibc Private Wealth Group, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 113 shares of UTHR stock, worth $35,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113
Holding current value
$35,826
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$210.76 - $249.51 $23,815 - $28,194
113 New
113 $25,000
Q2 2022

Aug 03, 2022

SELL
$174.81 - $241.14 $2,796 - $3,858
-16 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $2,658 - $3,423
16 New
16 $3,000
Q2 2018

Aug 02, 2018

SELL
$101.14 - $118.31 $1,820 - $2,129
-18 Closed
0 $0
Q1 2018

May 17, 2018

BUY
$107.21 - $151.94 $1,929 - $2,734
18 New
18 $2,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.